SÃO PAULO BRAZIL -- PHARMA UPDATE NEWS SERVICE™ -- SEPTEMBER 11, 2012: The First Latin American Pharmaceutical Compliance Congress, www.LatinAmericanPharmaCongress.com, October 2 - 4, 2012, will be held at the Hilton São Paulo Morumbi in São Paulo, Brazil. The Latin American Pharma Congress is sponsored by the Latin American Ethics and Compliance Network and cosponsored by the Pharmaceutical Compliance Forum. Plenary session presentations will be in Portuguese, Spanish and English with simultaneous translation.

FEATURING COMPLIANCE 2.0: THE FUTURE OF COMPLIANCE IN LATIN AMERICA BY:

Dr. Julien Durand, LLM, MBA, CHCP Regional Compliance Officer and Ethical Innovation Lead, AstraZeneca Latin America, Wilmington, DE, USA Arun Sharma, PhD Professor, Marketing, Academic Director, Johnson A. Edosomwan Leadership Institute, School of Business, University of Miami, Miami, FL, USA

Plenary session presentations will be in Portuguese, Spanish and English with simultaneous translation.

FIRST LATIN AMERICAN PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS AND BEST PRACTICES FORUM
ONSITE October 2 - 4, 2012 Hilton São Paulo Morumbi São Paulo, Brazil	OR	ONLINE In your own office or home live via the Internet with 24/7 access for six months

KEYNOTE SPEAKER

Joaquin Duato, MBA Worldwide Chairman, Pharmaceuticals Group, Johnson & Johnson, New Brunswick, NJ, USA

CO-LOCATED INDEPENDENT PRECONFERENCE EVENTS
IFPMA Code Workshop: Hands on Compliance Training for Company Compliance Professionals, Monday, October 1, 2012
IFPMA/Interfarma Latin America Regional Code Rollout, Morning of Tuesday, October 2, 2012

PLENARY SESSIONS

The Role of Global Compliance in the Pharmaceutical Enterprise Brazil's New Code and Collaborative Relationships with Other National Associations Global Compliance Codes Roundtable Latin American Compliance Roundtable How Pharmaceutical Companies Handle Misconduct Transparency International, Latin America Update Anti-Corruption and Anti-Bribery Compliance in Latin America Global Trends in Transparency and Disclosure Reporting Compliance and Ethics Departments as Business Partners Compliance Officer as Executive Compliance 2.0: The Future of Compliance in Latin America

AND MINI SUMMITS

Brazil Pharmaceutical and Medical Device Compliance Update Growing our own Compliance Professionals Cultural Components to Deter Fraud and Corruption in an Organization Knowing your Compliance Partners and Stakeholders Fair Market Value Update Structuring Mergers & Acquisitions and Joint Ventures in Latin Americas Mexico Pharmaceutical and Medical Device Compliance Update Building a Global Compliance Program Execution of the Compliance Program at Affiliates in Latin America Who is our Customer? - New Stakeholders and Strategies Pre-acquisition and Pre-merger Due Diligence; Assessing Contracts with Intermediaries Lessons Learned from Compliance Issues in the Latin American Medical Device Sector Analysis of Public Corruption Cases in Latin America Auditing and Monitoring Third Party Relationships

OTHER KEYNOTE FACULTY

Antonio Britto Executive Director, Interpharma, São Paolo, Brazil Giuseppe Falbo Business Practices Officer (Asia, Middle East, Africa and Latin America), Novartis International AG, Former Senior Director, Kroll Associates London, Former, Investigative Specialist, United States Secret Service, Former Maresciallo Aiutante, Guardia di Finanza, Basel, Switzerland Francisco de Paula Gomez President, AFIDRO (Asociación de Laboratorios Farmacéuticos de Investigación y Desarrollo), Bogotá, Colombia Rafael Gual Director General, CANIFARMA, Mexico City, Mexico Jose F. Zamarriego Izquierdo Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain Tamara Music Manager, Influenza Vaccines & Code Compliance, IFPMA, Geneva, Switzerland Chrisoula Nikidis Director, Ethics and Compliance, Canada's Research-Based Pharmaceutical Companies (Rx&D), Ottawa, ON, Canada Ronaldo Luiz Pires Legal Director, Interfarma, São Paulo, Brazil Heather Simmonds Director, Prescription Medicines Code of Practice Authority, London, UK Juan Francisco Millán Soberanes, MD Secretary and Executive Director, CETIFARMA, Mexico City, Mexico

FEATURED COMPLIANCE PROFESSIONALS AND IN HOUSE COUNSEL

Eunice Alcantara Compliance and Ethics Director Brazil, Bristol Myers Squibb Co., São Paulo, Brazil Ronny Arijs Vice President Global Sustainability and Chief Compliance Officer, Grunenthal, Member, EFPIA Compliance Workgroup, Former Senior Compliance Manager, GE Healthcare, Brussels, Belgium Vivian Lima-Barnett Latin America Ethics and Compliance Director, Abbott Laboratories, Abbott Park, IL, USA Diana Borges, MBA Director, Compliance/Regional Compliance Officer, Latin America, Teva Pharmaceuticals Americas, Miami, FL, USA Hedilene Cardoso Ethics and Compliance Associate Director, Eli Lilly and Company, São Paulo, Brazil Michael R. Clarke, Esq. Vice President, Ethics and Compliance Americas, Actavis, Former Vice President and Compliance Officer, Biomet Spine and Bone Healing Technologies; Former Vice President/Chief Ethics and Compliance Officer, University of Medicine and Dentistry of New Jersey, Morristown, NJ, USA José Francisco Compagno Fraud Investigation & Dispute Services, Ernst & Young LLP, São Paulo, Brazil Erika Wirtzbiki de Almeida, Pharm D, MBA Compliance Officer, GlaxoSmithKline, Riode Janeiro, Brazil Mauro Diaz, MBA Compliance Officer, GlaxoSmithKline, Rio de Janeiro, Brazil Dr. Julien Durand, LLM, MBA, CHCP Regional Compliance Officer and Ethical Innovation Lead, AstraZeneca Latin America, Wilmington, DE, USA Luciano Finardi Marketing Director, Eli Lilly and Company, São Paulo, Brazil Laura Giussani Ethics and Compliance Consultant, Eli Lilly and Company, Indianapolis, IN, USA Nancy A. Grygiel, JD, LLM Senior Director, Corporate Compliance, Business Compliance, International, Allergan, Irvine, CA, USA Rodrigo Lecuona Latin America Compliance Officer, Merck, Mexico City, Mexico Flavia Ribas Lopes Latin America Fraud Risk Director, Philips, São Paulo, Brazil Sergio Pinto, MBA, CCEP, HCC Director, Johnson & Johnson Medical Device Sector, São Paulo, Brazil Louis Ramos, Esq. Lead Compliance Counsel for Latin America, International R&D and Manufacturing, Pfizer Inc.; Former Assistant United States Attorney, United States Attorney's Office for the District of Columbia, Washington, DC Alexandre da Cunha Serpa, CCEP, CFE Country Compliance Head (Corporate) and Divisional Compliance Officer (Pharma), Novartis, São Paulo, Brazil Carlos Tessi, MD Director of Compliance, Global Pharmaceuticals, Bausch + Lomb, Former Vice President - Global Human Health Business Practices and Compliance Officer, Merck & Co. Inc., Madison, NJ, USA

FEATURED ACADEMICS, ADVISORS AND LEGAL COUNSEL

Ted Acosta, Esq. Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France Yogesh Bahl, MBA Partner, National Practice Leader - Life Sciences, Deloitte Financial Advisory Services LLP, New York, NY, USA Bridget Bourgeois Partner, Ernst & Young LLC, Atlanta, GA, USA William E. Buzzeo, MS Vice President and General Manager, Global Compliance Solutions, Cegedim Relationship Management, Richmond, VA, USA Alejandro Candioti, Esq. Partner, Candioti Gatto Bicain & Ocantos, Buenos Aires, Argentina Anita Cava, JD Professor of Business Law & Director, Business Ethics Program, School of Business and Co-director, UM Ethics Programs, University of Miami, Miami , FL, USA Eun Ah Choi, Esq. Partner, Hogan Lovells, Washington, DC Claudette M. Christian, Esq. Partner and Managing Partner, Rio de Janeiro Office (to be effective upon receipt of AOB licenses), Hogan Lovells, Washington, DC, USA and Rio de Janeiro, Brazil Gildas Durand Senior Manager, Ernst & Young LLP, Miami, FL, USA Eileen Erdos Principal, Fraud Investigation and Dispute Services, Ernst & Young LLP, Chicago, IL, USA Henrique Kruger Frizzo, Esq. Partner, Trench, Rossi e Watanabe, São Paulo, Brazil Jonathon Kellerman Principal, Pharmaceutical and Life Sciences Advisory Services, PwC LLP, Florham Park, NJ, USA Anup Kharode Director, Pharmaceutical R&D Advisory Services PwC LLP, Philadelphia, PA Keith M. Korenchuk, JD, MPH Partner, Arnold & Porter LLP, Washington, DC, USA Angela Kung, Esq. Partner, Pinheiro Neto, Professor of Legal Aspects of the Pharmaceutical Industry, Business School São Paulo, Professor of Regulation of the Pharmaceutical Industry, Fundação Getulio Vargas, São Paulo, Brazil Bruno Carneiro Maeda, LLM Partner, Trench, Rossi e Watanabe, Coordinator, Anticorruption Committee, Brazilian Institute of Business Law, São Paulo, Brazil Dianne Regina (Dianne) Phoebus, Esq. Partner, Baker & McKenzie, SC, Caracas, Venezuela Brian Riewerts Partner, Global Pharmaceuticals and Life Sciences, PwC LLP, Baltimore, MD, USA Dr. Arun Sharma, PhD Professor, Marketing, Academic Director, Johnson A. Edosomwan Leadership Institute School of Business, Miami, FL Peter Spivack, Esq. Co-Leader of the Investigations, White Collar, and Fraud Practice Area, Hogan Lovells, Washington, DC, USA Tamika Tremaglio, JD, MBA Principal, Deloitte Financial Advisory Services LLP, Washington, DC Sylvia Urquiza, Esq. Partner, Trench, Rossi e Watanabe, São Paulo, Brazil L. Stephan Vincze, JD, LL M, MBA National Managing Director, Life Sciences/Forensic and Dispute Services, Deloitte Financial Advisory Services, LLP, Boston, MA, USA

PARTICIPATION OPTIONS TRADITIONAL ONSITE ATTENDANCE Simply register, travel to the conference city and attend in person. Pros: subject matter immersion; professional networking opportunities; faculty interaction INTERNET INTERFACE SAMPLE Click here for a sample stream LIVE AND ARCHIVED INTERNET ATTENDANCE Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event. The archived conference includes speaker videos and coordinated PowerPoint presentations. Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office